Dr. Lawrence Kleinberg, MD

Dr. Kleinberg practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Kleinberg's NPI, 1952342214, was assigned on June 9, 2006. Dr. Kleinberg graduated from Yale School of Medicine in 1989. Dr. Kleinberg holds Maryland license D44461.

Dr. Kleinberg's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Kleinberg's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Kleinberg is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Kleinberg to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kleinberg practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Kleinberg's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kleinberg is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Kleinberg's licenses on file in 5 states: Maryland, District of Columbia, Virginia, North Carolina and New York.

Dmand AI lists bone cancer radiation, brain cancer radiation and brain tumor radiation among the conditions Dr. Kleinberg treats.

CMS data shows 2,444 Medicare services from Dr. Kleinberg across 18 procedure codes in 2024, for 305 Medicare patients. Medicare paid $269,105 for them.

CMS counts 305 Medicare patients who saw Dr. Kleinberg in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kleinberg's median patient age at 72, with 48% women.

In 2024, Dr. Kleinberg wrote 39 Medicare Part D claims for 20 patients. 92% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $326 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kleinberg for performance year 2024, reported as part of a group. CMS lists Dr. Kleinberg as offering telehealth.

Dmand AI links 161 papers to Dr. Kleinberg, published from 2006 to 2025. 2023 was the busiest year, with 18. The most frequent topics are Brain Neoplasms, Radiosurgery and Esophageal Neoplasms. Dr. Kleinberg has published most often in Int J Radiat Oncol Biol Phys. Dr. Kleinberg's most frequent co-authors are Kristin Janson Redmond, MD, Michael Lim, MD and Chetan Bettegowda, MD, PhD.

Dmand AI links Dr. Kleinberg to 10 clinical trials, 5 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Gliosarcoma. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins sponsors the most, 8.

CMS Open Payments shows 94 general payments to Dr. Kleinberg from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. Novocure Inc. paid the most, $24,360. It also lists 2 research payments totaling $19,849 in 2017.

Dmand AI lists 5 awards for Dr. Kleinberg, most recently America's Top Doctors in 2014.

Dr. Kleinberg graduated from Yale School of Medicine in 1989. Dr. Kleinberg is a member of ASCO.

Dr. Kleinberg is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.